Zoetis (ZTS) Total Current Liabilities (2012 - 2026)
Zoetis (ZTS) posted quarterly Total Current Liabilities of $2.1 billion for Q1 2026, down 39.35% year-over-year from $3.4 billion in Q1 2025, and down 5.52% quarter-over-quarter from $2.2 billion in Q4 2025.
Zoetis (ZTS) Total Current Liabilities (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Total Current Liabilities for 15 consecutive years, with $2.1 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 39.35% year-over-year to $2.1 billion; the TTM figure through Mar 2026 stood at $2.1 billion (down 39.35% YoY), while the FY2025 annual figure was $2.2 billion, down 36.31% from the prior year.
- Total Current Liabilities eased to $2.1 billion in Q1 2026 per ZTS's latest filing, from $2.2 billion in the prior quarter.
- Across five years, Total Current Liabilities topped out at $3.4 billion in Q4 2024 and bottomed at $1.6 billion in Q3 2023.
- Historically, Total Current Liabilities has averaged $2.4 billion across 5 years, with a median of $2.1 billion in 2026.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 95.79% — and 2023, when it tumbled 44.17%.
- Zoetis' Total Current Liabilities stood at $3.2 billion in 2022, then slumped by 40.35% to $1.9 billion in 2023, then surged by 80.62% to $3.4 billion in 2024, then sank by 36.31% to $2.2 billion in 2025, then decreased by 5.52% to $2.1 billion in 2026.
- Business Quant data shows ZTS's Total Current Liabilities at $2.1 billion in Q1 2026, $2.2 billion in Q4 2025, and $1.8 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 1.79 Bn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 662.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.06 Bn |
| Mar 31, 2026 | 2.05 Bn |
| Dec 31, 2025 | 2.17 Bn |
| Sep 30, 2025 | 1.81 Bn |
| Jun 30, 2025 | 3.37 Bn |
| Mar 31, 2025 | 3.39 Bn |
| Dec 31, 2024 | 3.41 Bn |
| Sep 30, 2024 | 1.70 Bn |
| Jun 30, 2024 | 1.80 Bn |
| Mar 31, 2024 | 1.91 Bn |
| Dec 31, 2023 | 1.89 Bn |
| Sep 30, 2023 | 1.61 Bn |
| Jun 30, 2023 | 1.77 Bn |
| Mar 31, 2023 | 1.92 Bn |
| Dec 31, 2022 | 3.17 Bn |
| Sep 30, 2022 | 2.88 Bn |
| Jun 30, 2022 | 3.05 Bn |
| Mar 31, 2022 | 3.03 Bn |
| Dec 31, 2021 | 1.80 Bn |
| Sep 30, 2021 | 1.47 Bn |